Mallory Wittig
Family · Metropolis, ILNPI 1114285517
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.5% of the total across 429 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 17.9% — the pattern of someone who eats at a lot of different presentations. Among family clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 429 payments — averaging $16.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- Novo Nordisk$1K
- GSK$863
- Bayer$476
- Johnson & Johnson$463
- Novartis$439
- plus $2K from 23 others
What the payments were for
- Food & beverage$6,946100%
- Education$340%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 60 | $1,251 |
| Novo Nordisk | 66 | $1,072 |
| GSK | 64 | $863 |
| Bayer | 25 | $476 |
| Johnson & Johnson | 30 | $463 |
| Novartis | 29 | $439 |
| Lilly USA, LLC | 22 | $400 |
| Amgen | 19 | $332 |
| Pfizer | 18 | $288 |
| AbbVie | 21 | $259 |
| Boehringer Ingelheim | 17 | $257 |
| Esperion Therapeutics, Inc. | 17 | $157 |
| Dexcom, Inc. | 9 | $151 |
| Biogen | 7 | $104 |
| Merck | 4 | $65 |
| E.r. Squibb & Sons, L.L.C. | 3 | $46 |
| Amarin Pharma, Inc. | 2 | $42 |
| Grifols USA, LLC | 2 | $38 |
| Sanofi-aventis U.S. LLC | 2 | $35 |
| Medtronic | 1 | $35 |
| Exact Sciences | 2 | $34 |
| Eisai Inc. | 2 | $32 |
| Gilead | 1 | $32 |
| Lundbeck LLC | 1 | $20 |
| Lantheus Medical Imaging, Inc. | 1 | $19 |
| Inspire Medical Systems, Inc. | 1 | $19 |
| Phathom Pharmaceuticals, Inc. | 1 | $18 |
| Electromed, Inc. | 1 | $18 |
| Edwards Lifesciences | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,980 in reported general payments places this provider in the 95th percentile of 4,941 family providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 235 | $176,483 |
| JardianceEmpagliflozin | 140 | $101,306 |
| OzempicSemaglutide | 66 | $72,904 |
| MounjaroTirzepatide | 51 | $55,778 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 73 | $51,904 |
| RybelsusSemaglutide | 32 | $39,447 |
| EntrestoSacubitril/Valsartan | 43 | $38,737 |
| TradjentaLinagliptin | 65 | $36,747 |
| JanuviaSitagliptin Phosphate | 54 | $33,116 |
| TrulicityDulaglutide | 27 | $30,966 |
| FarxigaDapagliflozin Propanediol | 31 | $23,675 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 28 | $17,404 |
| Tresiba Flextouch U-100Insulin Degludec | 14 | $16,158 |
| MyrbetriqMirabegron | 19 | $14,274 |
| KerendiaFinerenone | 22 | $13,923 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $288 | $176,483235 claims |
| Boehringer IngelheimJardiance, Tradjenta | $257 | $138,053205 claims |
| Novo NordiskOzempic, Rybelsus | $1,072 | $112,35098 claims |
| Lilly USA, LLCMounjaro, Trulicity | $400 | $86,74478 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $863 | $60,17493 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Brilinta | $1,251 | $53,63283 claims |
| NovartisEntresto | $439 | $38,73743 claims |
| MerckJanuvia | $65 | $33,11654 claims |
| BayerKerendia | $476 | $13,92322 claims |
| Johnson & JohnsonXarelto | $463 | $12,99116 claims |
| AbbVieLinzess | $259 | $6,51312 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,941 family providers in Illinois.
Other family in Metropolis
- Ruth CarricoChicago$578K
- Aleksandra BielawiecBarrington$373K
- Erin SieberNaperville$334K
- Jamie BroganChicago$282K
- Ashley NoethGlen Carbon$271K
- Marita KametasChicago$259K
- Shammona ClarkChicago$247K
- Amanda McKeeMount Vernon$242K
- Amy BrownellElk Grove Village$202K
- Brittony CroasdellChicago$192K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.